Applications, hearings, determinations, etc.: American Radiolabeled Chemical, Inc.,

[Federal Register: May 28, 2002 (Volume 67, Number 102)]

[Notices]

[Page 36916]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr28my02-81]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated November 15, 2001, and published in the Federal Register on December 21, 2001, (66 FR 65992), American Radiolabeled Chemical, Inc., 11624 Bowling Green Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic of controlled substances listed below:

Drug

Schedule

Gamma hydroxybutyric acid (2010)........... I Lysergic acid diethylamide (7315).......... I Dimethyltryptamine (7435).................. I Dihydromorphine (9145)..................... I Phencyclidine (7471)....................... II Cocaine (9041)............................. II Codeine (9050)............................. II Hydromorphone (9150)....................... II Oxycodone (9143)........................... II Thebaine (9333)............................ II Benzoylecgonine (9180)..................... II Meperidine (9230).......................... II Metazocine (9240).......................... II Morphone (9300)............................ II Oxymorphone (9652)......................... II

The firm plans to bulk manufacture small quantities of the listed controlled substances as radiolabeled compounds.

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of American Radiolabeled Chemical, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemical, Inc. on a regular basis to ensure that the company's continued registration is consistent with the public interest. These investigations have included inspection and testing of the company's physical security systems, audits of the company's records, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.

Dated: May 21, 2002. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 02-13262Filed5-24-02; 8:45 am]

BILLING CODE 4410-09-M